Modulation of TRAIL Cytotoxicity by Amiloride in Prostate Cancer
Abstract
The challenge today is to develop a cytotoxic agent that selectively induces cytotoxicity in prostate cancer cells but avoids significant toxicity to the normal tissues. In this study, we will develop a novel strategy by using TRAIL in combination with amiloride.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2006
- Accession Number
- ADA478465
Entities
People
- Ki Mo Kim
- Young-ho Kim
Organizations
- University of Pittsburgh